12/12/2024
3:59 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
9:00 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
5:13 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
5:16 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
1:36 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2024
10:41 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
7:06 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/05/2024
6:48 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
3:09 PM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:12 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/03/2024
3:27 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
6:55 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
11:55 AM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
11:44 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2024
5:34 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:27 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:24 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:57 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:04 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
7:08 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
10:33 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
4:59 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
2:37 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
6:10 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:31 PM | Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
5:56 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2024
3:42 PM | BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
12:36 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
10:26 AM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
3:13 PM | Corcept Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2024
4:13 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
4:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
3:54 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
12:54 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:46 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
12:30 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
9:16 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
5:47 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:21 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025!
Trump could trigger THIS crypto coin…
 YES, I WANT THE #1 CRYPTO NOW |
06/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:10 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:11 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:13 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
8:15 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
1:15 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
1:05 PM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:05 PM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:38 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:39 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:40 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:41 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:45 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:46 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:47 PM | Corcept Therapeutics (Filer)
| Form S-8 POS | |
05/31/2024
3:01 PM | Corcept Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/30/2024
8:00 PM | Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
7:03 PM | Corcept Therapeutics (Issuer)
Guyer William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:53 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
12:14 PM | Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
12:22 PM | Corcept Therapeutics (Subject)
Guyer William (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
5:41 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:42 PM | Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:47 PM | Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:25 PM | BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:28 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:30 PM | Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
5:08 PM | Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
7:32 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:32 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
11:24 AM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
11:35 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
7:23 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:05 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
10:39 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/18/2024
4:09 PM | Corcept Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:44 PM | Corcept Therapeutics (Filer)
| Form ARS | |
04/17/2024
5:05 AM | Corcept Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
6:00 PM | Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
3:43 PM | Corcept Therapeutics (Filer)
| Form DEF 14A | |
04/08/2024
5:16 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
11:40 AM | Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/03/2024
7:00 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
6:38 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad) This isn't just another investment.
It might be the last retirement stock you'll ever need.
But this window of opportunity is closing fast. Click here for the ticker >>> |
04/01/2024
9:03 AM | Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/29/2024
1:12 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
1:32 PM | Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
| Form SC 13G/A | |
03/27/2024
12:01 PM | Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:09 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:14 PM | Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:19 PM | Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:02 PM | Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
8:03 PM | Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
